Skip to main content

Hessekiel Jeffrey's Form 4 filing

Exelixis, Inc. (EXEL) · filed Dec 2, 2024

Accession no.
0000939767-24-000165
Filed
Dec 2, 2024
Trade date
Nov 27-29, 2024
Filing delay
5 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.20M. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hessekiel JeffreyCIK 0001599803Officer (EVP & General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 27, 2024Common StockMOption exerciseAcquired+129,314$18.80+$2,431,103.2644,967Direct
Nov 27, 2024Common StockFTax withholdingDisposed−98,908$35.93−$3,553,764.44546,059Direct
Nov 29, 2024Common StockSSaleDisposed−60,000$36.67F3−$2,200,200486,059Direct
Nov 29, 2024Common StockGGiftDisposed−15,000$0.00$0471,059Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 27, 2024Common StockMOption exerciseDisposed−129,314$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.36 to $36.93. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)